Boston Scientific Corp (BSX)
74.65
+0.10
(+0.13%)
USD |
NYSE |
May 17, 16:00
74.66
+0.01
(+0.01%)
Pre-Market: 20:00
Boston Scientific SG&A Expense (Annual): 5.19B for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 5.19B |
| December 31, 2022 | 4.52B |
| December 31, 2021 | 4.359B |
| December 31, 2020 | 3.787B |
| December 31, 2019 | 3.941B |
| December 31, 2018 | 3.569B |
| December 31, 2017 | 3.294B |
| December 31, 2016 | 3.099B |
| December 31, 2015 | 2.873B |
| December 31, 2014 | 2.902B |
| December 31, 2013 | 2.674B |
| December 31, 2012 | 2.535B |
| December 31, 2011 | 2.487B |
| December 31, 2010 | 2.58B |
| December 31, 2009 | 2.826B |
| December 31, 2008 | 3.126B |
| December 31, 2007 | 3.111B |
| Date | Value |
|---|---|
| December 31, 2006 | 2.675B |
| December 31, 2005 | 1.814B |
| December 31, 2004 | 1.742B |
| December 31, 2003 | 1.171B |
| December 31, 2002 | 1.002B |
| December 31, 2001 | 961.00M |
| December 31, 2000 | 867.00M |
| December 31, 1999 | 842.00M |
| December 31, 1998 | 755.00M |
| December 31, 1997 | 663.00M |
| December 31, 1996 | 533.00M |
| December 31, 1995 | 417.80M |
| December 31, 1994 | 127.00M |
| December 31, 1993 | 131.20M |
| December 31, 1992 | 105.90M |
| December 31, 1991 | 77.70M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
3.787B
Minimum
2020
5.19B
Maximum
2023
4.359B
Average
4.359B
Median
2021
SG&A Expense (Annual) Benchmarks
| ResMed Inc | 874.00M |
| Stryker Corp | 7.129B |
| Align Technology Inc | 1.703B |
| Abbott Laboratories | 10.95B |
| Axonics Inc | 235.32M |